Dengue fever in patients under biologics

被引：11
|
作者：
Deligny, Christophe [1 ]
de Bandt, Michel [1 ]
Dehlinger, Veronique [1 ]
Numeric, Patrick [2 ]
Cabie, Andre [3 ]
Lombard, Frederic [4 ]
Polomat, Katlyne [1 ]
JeanBaptiste, Georges [1 ]
Arfi, Serge [1 ]
机构：
[1] Univ Hosp Pierre Zobda Quitman, Serv Med Interne & Rhumatol 3C 5D, F-97261 Fort De France, Martinique, France
[2] Univ Hosp Pierre Zobda Quitman, Internal Med Unit 3D, F-97261 Fort De France, Martinique, France
[3] Univ Hosp Pierre Zobda Quitman, Serv Malad Infect, F-97261 Fort De France, Martinique, France
[4] Univ Hosp Pierre Zobda Quitman, Serv Hepatogastroenterol, F-97261 Fort De France, Martinique, France
来源：
JOURNAL OF CLINICAL VIROLOGY | 2014年 / 61卷 / 03期
关键词：
Biotherapy; Dengue fever; Rheumatoid arthritis; anti-TNF; Rituximab; NECROSIS-FACTOR-ALPHA; SEVERITY;
D O I：
10.1016/j.jcv.2014.08.011
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Dengue fever (DF) is an epidemic viral mosquito-borne infection limited to tropical and subtropical countries. Biological therapies have been frequently used for the last 15 years in the treatment of inflammatory rheumatic conditions like rheumatoid arthritis. However, no data is available regarding the characteristics of this infection in patients on biological therapy. Yet, numerous patients on biotherapy have holidays in countries where DF exists. Moreover, the mosquitoes Aedes albopictus, vector of this viral disease, is now found in some developed countries such as southern Europe and the USA, allowing the possibility of a DF outbreak. We conducted a survey of individuals on biotherapy and described a case series of the patients experiencing DF. Our 8 patients on biotherapy (anti-TNF, n = 6; rituximab, n = 2) for a rheumatic condition did not experience severe DF. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [1] Genetic diversity of the dengue virus population in dengue fever and dengue hemorrhagic fever patients
    Chin-inmanu, Kwanrutai
    Mairiang, Dumrong
    Khongthon, Phongphak
    Sangsrakru, Duangjai
    Tangphatsornruang, Sithichoke
    Tangthawornchaikul, Nattaya
    Malasit, Prida
    Suriyaphol, Prapat
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2023, 41 (04) : 361 - 371
  • [2] OUTCOME OF PATIENTS WITH DENGUE FEVER
    Fida, Zahid
    Khan, Zahidullah
    Khan, Abidullah
    Khan, Hamza
    Rehman, Faiz Ur
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2016, 14 (03): : 137 - 140
  • [3] Coagulation abnormalities in dengue and dengue haemorrhagic fever patients
    Hassan, Jawad
    Borhany, Munira
    Abid, Madiha
    Zaidi, Uzma
    Fatima, Naveena
    Shamsi, Tahir
    TRANSFUSION MEDICINE, 2020, 30 (01) : 46 - 50
  • [4] The Difference of Platelet Activating Factor Plasma Level between Dengue Hemorrhagic Fever and Dengue Fever patients
    Setiabudi, Djatnika
    Setiabudiawan, Budi
    Parwati, Ida
    Garna, Herry
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2013, 45 (04): : 251 - 256
  • [5] Predicting the mortality in geriatric patients with dengue fever
    Huang, Hung-Sheng
    Hsu, Chien-Chin
    Ye, Je-Chiuan
    Su, Shih-Bin
    Huang, Chien-Cheng
    Lin, Hung-Jung
    MEDICINE, 2017, 96 (37)
  • [6] Seroepidemiology of dengue and chikungunya fever in patients with rash and fever in Iran, 2017
    Tavakoli, Forough
    Rezaei, Farhad
    Shafiei-Jandaghi, Nazanin Zahra
    Shadab, Azadeh
    Mokhtari-Azad, Talat
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [7] Spectrum of cardiac involvement in patients with dengue fever
    Shah, Chintan
    Vijayaraghavan, Govindan
    Kartha, Chandrasekharan C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 324 : 180 - 185
  • [8] Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations
    Orsi, Fernanda A.
    Angerami, Rodrigo N.
    Mazetto, Bruna M.
    Quaino, Susan K. P.
    Santiago-Bassora, Fernanda
    Castro, Vagner
    de Paula, Erich V.
    Annichino-Bizzacchi, Joyce M.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [9] Dengue Fever
    Kutsuna, Satoshi
    Ohmagari, Norio
    INTERNAL MEDICINE, 2014, 53 (15) : 1727 - 1727
  • [10] NS 1 lasts longer than the dengue virus nucleic acid in the clinically suspected patients with dengue fever and dengue haemorrhagic fever
    Sirisena N.
    Noordeen F.
    Fernando L.K.
    VirusDisease, 2017, 28 (3) : 341 - 344
12345